pharma · Diabetic Macular Edema · Non-infectious Uveitis Affecting the Posterior Segment of the Eye · ANIP
ANI PHARMACEUTICALS
ANI PHARMACEUTICALS INC
ANI PHARMACEUTICALS patent portfolio — 7 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 500 Alexander Park, Princeton, New Jersey 08540, US
- Employees
- 678
- Programs
- 11
- Drugs
- 7
- Patents
- 7
ANI PHARMACEUTICALS patents
7 pharmaceutical patents indexed for ANI PHARMACEUTICALS. 0 expire within 24 months.
ANI PHARMACEUTICALS has 7 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12350245
Stable oral suspensions of baclofen
granted -
US 12324787
Kits for preparing and delivering purified corticotropin
granted -
US 12233105
Methods for storing and warming purified corticotropin compositions
granted -
US 12133831
Kits for preparing and delivering purified corticotropin
granted -
US 12102662
Methods for storing and warming purified corticotropin compositions
granted -
US 11975047
Methods for storing and warming purified corticotropin compositions
granted -
US 11857524
Stable oral suspensions of baclofen
granted
Frequently asked questions
How many patents does ANI PHARMACEUTICALS have?
7 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do ANI PHARMACEUTICALS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.